These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 24703394)
1. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis. Moreno-Martet M; Espejo-Porras F; Fernández-Ruiz J; de Lago E CNS Neurosci Ther; 2014 Sep; 20(9):809-15. PubMed ID: 24703394 [TBL] [Abstract][Full Text] [Related]
2. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors. Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1 Rodríguez-Cueto C; Santos-García I; García-Toscano L; Espejo-Porras F; Bellido M; Fernández-Ruiz J; Muñoz E; de Lago E Biochem Pharmacol; 2018 Nov; 157():217-226. PubMed ID: 30076846 [TBL] [Abstract][Full Text] [Related]
4. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118 [TBL] [Abstract][Full Text] [Related]
5. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors. Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655 [TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. Witting A; Weydt P; Hong S; Kliot M; Moller T; Stella N J Neurochem; 2004 Jun; 89(6):1555-7. PubMed ID: 15189359 [TBL] [Abstract][Full Text] [Related]
7. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320 [TBL] [Abstract][Full Text] [Related]
8. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555 [TBL] [Abstract][Full Text] [Related]
9. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Kim J; Kim TY; Cho KS; Kim HN; Koh JY Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729 [TBL] [Abstract][Full Text] [Related]
10. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. Chang Q; Martin LJ J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903 [TBL] [Abstract][Full Text] [Related]
11. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model. Zhang JJ; Zhou QM; Chen S; Le WD CNS Neurosci Ther; 2018 Dec; 24(12):1163-1174. PubMed ID: 29656576 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of CB Fernández-Trapero M; Espejo-Porras F; Rodríguez-Cueto C; Coates JR; Pérez-Díaz C; de Lago E; Fernández-Ruiz J Dis Model Mech; 2017 May; 10(5):551-558. PubMed ID: 28069688 [TBL] [Abstract][Full Text] [Related]
13. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1 Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394 [TBL] [Abstract][Full Text] [Related]
15. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622 [TBL] [Abstract][Full Text] [Related]
17. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Feliú A; Moreno-Martet M; Mecha M; Carrillo-Salinas FJ; de Lago E; Fernández-Ruiz J; Guaza C Br J Pharmacol; 2015 Jul; 172(14):3579-95. PubMed ID: 25857324 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis. Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562 [TBL] [Abstract][Full Text] [Related]
19. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. Apolloni S; Fabbrizio P; Amadio S; Volonté C J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088 [TBL] [Abstract][Full Text] [Related]
20. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model. Wang R; Zhang D Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]